Eric Fischer

Eric Fischer is currently a Professor at Harvard Medical School since October 2015. Eric is also the Co-founder and SAB Member at Neomorph, Inc. and Civetta Therapeutics. Eric is the Director at DFCI Center for Protein Degradation and a Principal Investigator at Dana-Farber Cancer Institute. In the past, Eric served as a Postdoctoral fellow and PhD student at Friedrich Miescher Institute for Biomedical Research. Eric has a diverse background, including owning useKit AG and working as the Technical Director at fgi Fischer Group International GmbH. Eric also completed their education with a PhD in Biochemistry, Biophysics, and Molecular Biology from the University of Basel.